Health and Family Welfare Ministry of India on January 19 said that in case of the Covaxin which has been given emergency use authorization under clinical trial mode (Covaxin), hospitalization cost would be borne by authorities.
He said, "There are two vaccines.
One of the two vaccines is given emergency use authorization under clinical trial mode.
In a document for this vaccine, it's mentioned that if there's causal relation between immunization and adverse event weather it is severe or serious, hospitalization cost would be borne by authorities."
